Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€36.83

€36.83

1.490%
0.54
1.490%
€95.16
 
02.04.26 / Tradegate WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Corcept

sharewise wants to provide you with the best news and tools for Corcept, so we directly link to the best financial data sources.

News

Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week: https://g.foolcdn.com/editorial/images/863248/two-people-participating-in-a-telehealth-session.jpg
Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week

One of the top-performing healthcare stocks mid-week was Corcept Therapeutics (NASDAQ: CORT), and it was little wonder -- the company was granted U.S. Food and Drug Administration (FDA) approval for

Why Investors Strapped a Rocket to Corcept Therapeutics Stock on Wednesday: https://g.foolcdn.com/editorial/images/862440/healthcare-professional-inspecting-charts.jpg
Why Investors Strapped a Rocket to Corcept Therapeutics Stock on Wednesday

Corcept Therapeutics (NASDAQ: CORT) took its investors for quite a ride on Hump Day. The commercial-stage biotech earned its latest nod from a regulator that afternoon and, not surprisingly, its

Corcept Insider Transaction Explained After Shares Tumble 50% in One Day
Corcept Insider Transaction Explained After Shares Tumble 50% in One Day

On Tuesday, William Guyer, the chief development officer of Corcept Therapeutics (NASDAQ:CORT), exercised and immediately sold 20,000 shares through open-market transactions totaling approximately